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We were very glad to read the six commentaries about our scoping review on the needs and challenges of health systems that responsible 
innovation in health (RIH) could address. The commentators 
offered great suggestions to further research on RIH and 
health systems. We provide clarifications to their queries and 
explain why revisiting the relationship between systems of 
innovation and health systems is necessary to realize a “giant 
leap” towards RIH.1
Using the Human Development Index to Classify System-
Level Needs and Challenges
While the reason we used the Human Development Index 
(HDI) to classify our data was unclear for van Olmen et al,2 
Buttigieg3 underscored that RIH should be discussed in view 
of the values that underlie health systems. The assumption 
is that using a health system taxonomy would have showed 
variations that could be associated to different types of health 
system. The fact that only a small portion of the challenges 
reported in our corpus of articles fell into the “principles and 
values” (6%) category wherein the subcategory “inequalities” 
dominated by far lends support to the call for further research 
on how values such as solidarity, equity or universality get 
operationalized in health systems. The analytical thrust of our 
scoping review was not to account for what health systems “are 
and do,”4 but it would be enlightening to apply “causal loop 
diagramming”2 techniques to better address the interactions 
between health system components and innovation. 
A classification based on the HDI has important strengths. 
First, it enabled us to include articles examining health 
systems in low- and middle-income countries that may not 
easily fit in taxonomies created for high-income countries. 
Second, by describing challenges reported in each of the four 
HDI groups, our findings captured the heterogeneity that 
exists within countries sharing a similar level of development. 
Third, the HDI combines indicators that are less volatile over 
time and directly relevant to population health. 
Differentiating Health Systems From Systems of Innovation 
Peine5 and Stahl6 underscored the reciprocal relationship 
between health systems and innovations, a point we 
discussed elsewhere.7 What should have been understood as 
“two analytically separate entities”5 are not ‘health systems’ 
and ‘innovation.’ The distinction upon which RIH builds 
is between health systems and systems of innovation. Both 
follow from a set of institutionalized practices that have been 
shaped independently from one another to meet the aims of 
health policies, on the one hand, and of innovation policies, 
on the other hand. Though we agree that a dichotomy between 
‘technology push’ and ‘demand pull’4 may be misleading, what 
RIH aims to achieve is to realign the goals pursued by systems 
of innovation with the goals of health systems. To move 
towards this aim, it is first necessary to articulate what health 
systems need and “want” from innovation. 
Whereas Stahl6 found the aggregate data presented in 
our scoping review “too abstract,” Abrishami and Repping1 
underscored the practical insights it offered to those who 
finance and develop innovations (eg, designing “readily-
scalable solutions,” making entrepreneurs more “responsive” 
to public health priorities). If system-level demand remains 
unarticulated, innovators will pursue a technology-push 
strategy or turn to end-users for identifying needs and 
opportunities. While an individual-level approach is relevant 
for designing innovations that suit the needs of physicians, 
nurses, patients or informal caregivers, it cannot provide the 
systemic responsiveness that RIH requires. Responding to 
user demand is bound to reproduce innovations like the Da 
Vinci surgical robot described by van Lente.4
A “better diagnosis”4 of why health systems do not deliver 
their promises could start with recognizing that they were 
created decades ago and evolved along a path-dependent 
trajectory wherein innovations were geared at supporting 
medical practices and not at improving population health 
in an equitable and sustainable way. A focus on what is 
“medically required” left very little room to innovations 
providing a better response to chronic diseases, ageing and 
home care needs. 
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Who Is Responsible for Responsible Innovation in Health?
It would seem presumptuous to disagree with the notion that 
steering technological development is very difficult.2,4,6 Yet, 
how do scholars explain the striking similarities between 
technologies developed in the past decades? Weren’t they 
developed with a certain demand in mind and a certain 
understanding of market opportunities? Today, we have the 
technologies that our systems of innovation were structured 
to generate and that our health systems were willing to pay 
for.7 What RIH suggests is that it is both possible and desirable 
to foreground system-level challenges as opportunities for 
innovation and to reward entrepreneurial activities that align 
with them.8 
RIH calls for “an entire research programme”6 and Stahl6 
nails down the key question: who is responsible for RIH? 
Our own work seeks to clarify the “overlapping networks”6 
of responsibilities that connect stakeholders together. In a 
qualitative study, we found that Canadian health innovators 
were supportive of RIH and called for regulations and public 
policies to foster its implementation.9 In a meta-ethnography 
on why and how responsible innovations had been developed, 
we observed the key role of public policies, which can create 
transitory “protective niches” where novel kinds of innovation 
may be tested and adapted and where new players can enter 
the market and gain legitimacy.10 There are thus reasons to 
believe that many stakeholders feel responsible for RIH. 
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